Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 10 studies | 51% ± 19% | |
epithelial cell of proximal tubule | 6 studies | 27% ± 7% | |
enterocyte | 6 studies | 22% ± 5% | |
alveolar macrophage | 3 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of GPD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 93% | 8532.64 | 210 / 226 | 87% | 47.90 | 355 / 406 |
kidney | 85% | 8536.73 | 76 / 89 | 82% | 49.50 | 737 / 901 |
breast | 86% | 33066.66 | 394 / 459 | 48% | 17.65 | 536 / 1118 |
brain | 19% | 1106.31 | 514 / 2642 | 85% | 27.72 | 599 / 705 |
muscle | 99% | 18711.65 | 797 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 48358.00 | 1188 / 1204 | 0% | 0 | 0 / 0 |
intestine | 16% | 1029.26 | 153 / 966 | 57% | 11.15 | 301 / 527 |
pancreas | 2% | 57.82 | 5 / 328 | 69% | 15.97 | 122 / 178 |
stomach | 2% | 263.13 | 6 / 359 | 65% | 14.51 | 186 / 286 |
lung | 23% | 605.99 | 135 / 578 | 24% | 3.29 | 273 / 1155 |
bladder | 14% | 408.00 | 3 / 21 | 22% | 3.81 | 109 / 504 |
esophagus | 3% | 172.23 | 41 / 1445 | 33% | 8.18 | 60 / 183 |
thymus | 5% | 248.68 | 32 / 653 | 26% | 2.34 | 158 / 605 |
skin | 18% | 810.41 | 333 / 1809 | 10% | 2.58 | 48 / 472 |
adrenal gland | 7% | 200.95 | 17 / 258 | 6% | 1.56 | 14 / 230 |
ovary | 0% | 0 | 0 / 180 | 12% | 1.33 | 53 / 430 |
heart | 12% | 408.59 | 106 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 11% | 1339.26 | 150 / 1335 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 10% | 2.23 | 44 / 459 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.16 | 1 / 45 |
prostate | 0% | 35.73 | 1 / 245 | 1% | 0.08 | 6 / 502 |
peripheral blood | 1% | 17.34 | 7 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 11.35 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0071320 | Biological process | cellular response to cAMP |
GO_0046486 | Biological process | glycerolipid metabolic process |
GO_0006127 | Biological process | glycerophosphate shuttle |
GO_0006094 | Biological process | gluconeogenesis |
GO_0006072 | Biological process | glycerol-3-phosphate metabolic process |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0046168 | Biological process | glycerol-3-phosphate catabolic process |
GO_0006116 | Biological process | NADH oxidation |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0051287 | Molecular function | NAD binding |
GO_0004368 | Molecular function | glycerol-3-phosphate dehydrogenase (quinone) activity |
GO_0141152 | Molecular function | glycerol-3-phosphate dehydrogenase (NAD+) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GPD1 |
Protein name | Glycerol-3-phosphate dehydrogenase 1 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8) Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8) |
Synonyms | hCG_20197 |
Description | FUNCTION: Has glycerol-3-phosphate dehydrogenase activity. . FUNCTION: Has glycerol-3-phosphate dehydrogenase activity. . |
Accessions | A0A024R138 F8VSE8 P21695 ENST00000547964.5 ENST00000548814.1 [P21695-2] ENST00000301149.8 [P21695-1] |